These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 9564231

  • 1. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M.
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 5. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML, Garfield LD, Teitelbaum S, Civitelli R, Mulsant BH, Reynolds CF, Dixon D, Doré P, Lenze EJ.
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Velaxin (venlafaxine) in the treatment of anxious depression].
    Il'ina NA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008 May; 108(3):24-8. PubMed ID: 18427537
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 May; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 9. Dose-related paresthesias with venlafaxine.
    Angelo LJ, Lee KC.
    J Pharm Pract; 2013 Oct; 26(5):514-7. PubMed ID: 23764565
    [Abstract] [Full Text] [Related]

  • 10. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA, Mourad L, ter Haar J, Egberts AC.
    Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1370-2. PubMed ID: 12892015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyponatremia with venlafaxine.
    Masood GR, Karki SD, Patterson WR.
    Ann Pharmacother; 1998 Jan 12; 32(1):49-51. PubMed ID: 9475820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of venlafaxine.
    Ballenger JC.
    J Clin Psychopharmacol; 1996 Jun 12; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
    [Abstract] [Full Text] [Related]

  • 17. [Effects of venlafaxine extended release formulation on the clinical management of patients].
    Carrasco JL, Díaz-Marsá M, López-Ibor JJ.
    Actas Esp Psiquiatr; 2005 Jun 12; 33(3):147-53. PubMed ID: 15918081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F.
    Can J Psychiatry; 2005 Mar 12; 50(3):184. PubMed ID: 15830829
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.